K Pro is Owkin's AI agent for biology that leverages multimodal patient data to enable smarter biopharma decision making and continuously learns from real-world data, user feedback, and clinical validation, connecting research to care. It supports the entire drug development pipeline—from target discovery to portfolio strategy—allowing natural-language queries and delivering publication-ready, evidence-based outputs such as target prioritization, tractability assessments, patient-subgroup characterization, comprehensive reports, and cross-modality biomarker validation. Built on intelligent orchestration of specialized AI skills within a single agent, K Pro taps into Owkin's MOSAIC data network (2700 cancer samples across 11 tumor types from 104 hospitals) and can be deployed on your own infrastructure with ISO27001/GDPR compliance, enabling data integration and reproducible workflows.
AI named Owkin K Pro in September 2026.
AI cited owkin.com in these answers, after benchling.com.
owkin.com/k-os/k-pro 13%Other sites 87%